{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:41:17Z","timestamp":1791600077098,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T00:00:00Z","timestamp":1257552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9351-4","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T16:44:49Z","timestamp":1257525889000},"page":"1149-1154","source":"Crossref","is-referenced-by-count":22,"title":["The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater"],"prefix":"10.1007","volume":"27","author":[{"given":"Seung Tae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Taek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Kyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Seok","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ki","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,7]]},"reference":[{"key":"9351_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9610(00)00405-0","volume":"180","author":"M Bouvet","year":"2000","unstructured":"Bouvet M, et al. Factors influencing survival after resection for periampullary neoplasms. Am J Surg. 2000;180:13\u20137.","journal-title":"Am J Surg"},{"key":"9351_CR2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ije\/25.4.722","volume":"25","author":"JS Chow","year":"1996","unstructured":"Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973\u20131990. Int J Epidemiol. 1996;25:722\u20138.","journal-title":"Int J Epidemiol"},{"key":"9351_CR3","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U","volume":"86","author":"JR Howe","year":"1999","unstructured":"Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American college of surgeons commission on cancer and the American cancer society. Adenocarcinoma of the small bowel: review of the National cancer data base, 1985\u20131995. Cancer. 1999;86:2693\u2013706.","journal-title":"Cancer"},{"key":"9351_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9610(00)00405-0","volume":"180","author":"M Bouvet","year":"2000","unstructured":"Bouvet M, et al. Factors influencing survival after resection for periampullary neoplasms. Am J Surg. 2000;180:13\u20137.","journal-title":"Am J Surg"},{"key":"9351_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archsurg.1991.01410270099016","volume":"126","author":"JR Monson","year":"1991","unstructured":"Monson JR, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg. 1991;126:353\u20137.","journal-title":"Arch Surg"},{"key":"9351_CR6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/bjs.1800821233","volume":"82","author":"J Klempnauer","year":"1995","unstructured":"Klempnauer J, Ridder GJ, Pichlmayr R. Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg. 1995;82:1686\u201391.","journal-title":"Br J Surg"},{"key":"9351_CR7","volume-title":"SEER survival monograph: cancer survival among adults\u2013US SEER program, 1998\u20132001, patients and tumor characteristics","author":"CMA Key","year":"2007","unstructured":"Key CMA. Cancer of the liver and biliary tract. In: Ries LAG, et al., editors. SEER survival monograph: cancer survival among adults\u2013US SEER program, 1998\u20132001, patients and tumor characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 2007. NIH Pub. No. 07-6215."},{"key":"9351_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","volume":"10","author":"MK Gibson","year":"2005","unstructured":"Gibson MK, Holcroft CA, Kvols LK, Haller D. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005;10:132\u20137.","journal-title":"Oncologist"},{"key":"9351_CR9","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","volume":"27","author":"MJ Overman","year":"2009","unstructured":"Overman MJ, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598\u2013603.","journal-title":"J Clin Oncol"},{"key":"9351_CR10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/annonc\/mdn717","volume":"20","author":"YK Kang","year":"2009","unstructured":"Kang YK, et al. Capecitabine\/cisplatin versus 5-fluorouracil\/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009;20:666\u201373.","journal-title":"Ann Oncol"},{"key":"9351_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.bjc.6602336","volume":"92","author":"HJ Kang","year":"2005","unstructured":"Kang HJ, et al. Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy. Br J Cancer. 2005;92:246\u201351.","journal-title":"Br J Cancer"},{"key":"9351_CR12","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3748\/wjg.15.2689","volume":"15","author":"G Rosati","year":"2009","unstructured":"Rosati G, Ferrara D, Manzione L. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol. 2009;15:2689\u201392.","journal-title":"World J Gastroenterol"},{"key":"9351_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CAD.0b013e328325a9ec","volume":"20","author":"MA Salah-Eldin","year":"2009","unstructured":"Salah-Eldin MA, Ebrahim MA MSAL-A. Phase II study of capecitabine plus cisplatin in patients with gastric cancer. Anticancer Drugs. 2009;20:191\u20136.","journal-title":"Anticancer Drugs"},{"key":"9351_CR14","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/cncr.23822","volume":"113","author":"MJ Overman","year":"2008","unstructured":"Overman MJ, et al. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008;113:2038\u201345.","journal-title":"Cancer"},{"key":"9351_CR15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000089678","volume":"69","author":"C Locher","year":"2005","unstructured":"Locher C, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology. 2005;69:290\u20134.","journal-title":"Oncology"},{"key":"9351_CR16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cncr.21741","volume":"106","author":"ST Kim","year":"2006","unstructured":"Kim ST, et al. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer. 2006;106:1339\u201346.","journal-title":"Cancer"},{"key":"9351_CR17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","volume":"230","author":"JH Klinkenbijl","year":"1999","unstructured":"Klinkenbijl JH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776\u201382. discussion 82\u20134.","journal-title":"Ann Surg"},{"key":"9351_CR18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","volume":"31","author":"SS Sikora","year":"2005","unstructured":"Sikora SS, et al. Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol. 2005;31:158\u201363.","journal-title":"Eur J Surg Oncol"},{"key":"9351_CR19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JCO.1997.15.3.928","volume":"15","author":"FR Spitz","year":"1997","unstructured":"Spitz FR, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928\u201337.","journal-title":"J Clin Oncol"},{"key":"9351_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0142(19840101)53:1<23::AID-CNCR2820530106>3.0.CO;2-U","volume":"53","author":"D Jigyasu","year":"1984","unstructured":"Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer. 1984;53:23\u20135.","journal-title":"Cancer"},{"key":"9351_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01. coc.0000214931.01062.01","volume":"29","author":"PN Fishman","year":"2006","unstructured":"Fishman PN, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006;29:225\u201331.","journal-title":"Am J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9351-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:42Z","timestamp":1559442162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9351"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9351-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,7]]}}}